Skip to main content
. Author manuscript; available in PMC: 2017 Sep 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2016 Jul 6;25(9):1341–1347. doi: 10.1158/1055-9965.EPI-16-0176

Table 2.

Characteristics of study participants by alternative COPD measures.

Variable Lung Cancer Cases Controls Test of Homogeneity
Self-reported emphysema (n, %)1
 No 256 (82.8) 677 (91.2) <0.001
 Yes 53 (17.2) 66 (8.9)
Self-reported COPD (n, %)1
 No 211 (67.8) 572 (77.2) 0.002
 Yes 100 (32.2) 169 (22.8)
Emphysema on CT scan (n,%)
 No 109 (36.9) 382 (52.6) <0.001
 Yes 186 (63.1) 344 (47.4)
GOLD COPD severity (n, %)
 0 (none) 157 (49.5) 505 (67.7) <0.001
 1 (mild) 20 (6.3) 37 (5.0)
 2 (moderate) 88 (27.8) 133 (17.8)
 3 (severe) 43 (13.6) 63 (8.4)
 4 (very severe) 9 (2.8) 8 (1.1)
Emphysema on qCT (median, IQR)2 1.8 (3.8) 1.1 (2.6) <0.001
Air trapping on qCT (median, SD)3 23.5 (19.7) 16.6 (17.3) <0.001
Emphysema on qCT2 (threshold value of 4.8%)
 No 220 (76.4) 606 (84.6) 0.002
 Yes 68 (23.6) 110 (15.4)
Air trapping on qCT3 (threshold value of 19.5%)
 No 151 (52.4) 493 (68.7) <0.001
 Yes 137 (47.6) 225 (31.3)
1

Self-report of emphysema and COPD (including reports of COPD, chronic bronchitis and/or emphysema) at least one year prior to diagnosis/interview.

2

Percent of total lung voxels < -950 HU in inspiration across both lungs.

3

Percent of total lung voxels < -856 HU in expiration across both lungs.